Recent commentary has highlighted CRISPR Therapeutics’ expanding gene-editing pipeline, including cardiovascular candidates like CTX310 and CTX320 and programs in type 1 diabetes, alongside fresh Buy ...
Scientists have gained tremendous control over the genome with CRISPR editing systems, that use a guide RNA molecule to ...
Wondering if CRISPR Therapeutics at around US$51.22 is pricing in too much hope or leaving room on the table? This article walks through what the current share price may be implying about the company.
Invasive species represent a $5.4 trillion global problem, with U.S. economic impact alone exceeding $500 billion annually.
The biotech revolution spent decades trying to harness power for medicine. The next chapter is harnessing it for everything ...
The cover of National Geographic’s March issue featured a tractor tire dangling from a thread. Not metaphorically, but literally, because the thread is spider silk — five times stronger than steel but ...
Scientists at Rothamsted Research have developed wheat with dramatically reduced levels of asparagine, using gene editing ...
A recent study from scientists at the Garvan Institute of Medical Research has uncovered an important clue about why some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results